Symbols / DVAX Dynavax Technologies Corp
DVAX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 1.82B | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | 2025-11-05 | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | — | Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge - Yahoo Finance Sat, 10 Jan 2026 08
- Dynavax Stock (+38%) : Sanofi Buyout Validates Vaccine Pipeline - Trefis hu, 25 Dec 2025 08
- Dynavax Technologies (DVAX) Stock Analysis: Exploring the 3.23% Upside Potential in the Burgeoning Vaccine Market - DirectorsTalk Interviews ue, 17 Feb 2026 08
- Shingles and hepatitis B: why one vaccine maker is being bought out - Stock Titan ue, 23 Dec 2025 08
- Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying - Investopedia Wed, 24 Dec 2025 08
- Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring - FinancialContent Wed, 24 Dec 2025 08
- Why Dynavax Stock Soared Today - The Motley Fool Wed, 24 Dec 2025 08
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX) - PR Newswire Mon, 05 Jan 2026 08
- Sanofi Buyout Ends Dynavax Listing And Shifts Vaccine Upside To Group - Yahoo Finance ue, 10 Feb 2026 08
- Sanofi to merge Dynavax (NASDAQ: DVAX) after $15.50 per share cash tender - Stock Titan ue, 10 Feb 2026 08
- Dynavax Stock (+38%): Sanofi Buyout Closes Valuation Gap - Trefis hu, 25 Dec 2025 08
- Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal - Yahoo Finance Wed, 24 Dec 2025 08
- Is It Time To Reassess Dynavax (DVAX) After The Agreed Sanofi Cash Acquisition Deal - Yahoo Finance ue, 10 Feb 2026 08
- Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger - Yahoo Finance hu, 25 Dec 2025 08
- Jim Cramer Highlights Sanofi’s Bid for Dynavax - Yahoo Finance Wed, 14 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|